림프세포증식성 질환에서 효과를 보인 부분적 비동맥 색전술 1례
Successful Treatment with Partial Splenic Embolization in a Case of Post-transplantations Lymphoproliferative Disease with Persistent Hypersplenism
1
조회
0
다운로드
0
인용
0
참고문헌
초록
저자들은 간 이식 후 지속적 비기능 항진에 발생된 내과적 치료에 반응하지 않는 림프세포증식성질환의 6세된 남아에서 부분적 비동맥 색전술을 치료의 한 방법으로 선택하였다. 비기능항진의 억제 효과로 면역력 증강을 통해 혈액학적 호전을 유도하고자 하였으며 치료 후 PTLD의 호전을 보인 1례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.
Abstract
Posttranplantations lymphoproliferative disease (PTLD) is a common and life-threatening complication for soid organ transplantation associated with the use of chronic immunosuppression and Epstein-Barr virus. There is no standardized treatment algorithm, but numerous management strategies are vaiable. Partial splenic embolization (PSE) had been demonstrated to be an effetive alternatie to splenectomy for patients hypersplenism and portal hypertension. PSE has the advantages of non-invasive intervention and resolution of the complications of hypersplenism. We report the effect of the PSE in a 6-year old male liver transplantation recepient with PTLD who has undergone persistent hypersplenism post-transplant. We reduced immunosuppression agent, started antiviral agent. We started with interferon and IV globulin one month after admission. Hepatosplenomegaly and cervical lymphadenopathy were improved. But fever was not subside. We selectively embolized the lower pole of the spleen to achieve a 50～60% reduction in flow as determined by angiography. After embolization, fever subside and peripheral blood findings were improved. Follow up abdominal CT revealed reduced volume of spleen due to ischemic change and there was no multiple enlarged mesenteric lymphnode compared to preembolization state. We thick that PSE is a safe an effetive treatment modality of PTLD with persistent hypersplenism in patients twho failed to medical treatment.
참고문헌 (20)
- "Partial splenic embolization for hypersplenism before and after transplantation", 16(7), pp.59~61 (2002)
- "Lymphoproliferative disease after lung transplantation in transplanted lung", 34, pp.956~959 (2001)
- "A case of posttransplant lymphoproliferative disease(PTLD)following renal transplantation in a child", 6, pp.123~130 (2002)
- "Embolization of the spleen for treatment of splenomegaly and hypersplenism in patients with portal hypertension", 14, pp.457~64 (1979)
- "Partial splenic embolization:long-term outcome", 387, pp.421~426 (2003)
- "Long-term results of initial and repeated partial splenic embolizaton for the treatment of chronic idiopathic thrombocytopenic purpura", 179, pp.1323~1326 (2002)
- "Changes in portal hemodynamics and hepatic function after partial splenic embolization", pp.33~41
- "Long-term hematolgical and biochemical effects of partial splenic embolization in hepatic cirrhosis", 49, pp.1445~1448 (2002)
- "Two cases of posttransplant lymphoproliferative disorders in recipients of liver transplantation", 56, pp.399~402 (1999)
- "Lymphoproliferative disorders after organ transplantation in children", 67, pp.990~998 (1999)
- "Post-transplant lymphoproliferative disease in children", 154, pp.250~257 (2001)
- "The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation,and its manifestations in children", 45, pp.719~27 (1988)
- "An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK 506 after liver transplantation", 59, pp.524~529 (1995)
- "Epstein-Barr virus and post- transplant lymphoproliferative disease", 6, pp.456~464 (2002)
- "Expression of Epstein-Barr virus-encoded small RNA(by the EBER- 1 gene)in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease", 327, pp.1710~4 (1992)
- "The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation", 28, pp.380~385 (1999)
- "The role of immunosuppression in lymphoma formation", 20, pp.343~355 (1998)
- "The antiviral prophylaxis of posttransplant lymphoproliferative disorder", 20, pp.437~453 (1998)
- "Interferon-α treatment posttransplant lymphoproliferative disorder in recipients of solid organ transplants", 66, pp.1770~1779 (1998)
- "Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation", 69, pp.9982~9984 (2001)